NMDA receptor pathways as drug targets

@article{Kemp2002NMDARP,
  title={NMDA receptor pathways as drug targets},
  author={J. Kemp and Ruth M. McKernan},
  journal={Nature Neuroscience},
  year={2002},
  volume={5 Suppl 1},
  pages={1039-1042}
}
Since the mid 1980s, there has been a great deal of enthusiasm within both academia and industry about the therapeutic potential of drugs targeting the NMDA subtype of glutamate receptors. That early promise is just beginning to translate into approvable drugs. Here we review the reasons for this slow progress and critically assess the future prospects for drugs that act on NMDA receptor pathways, including potential treatments for some major disorders such as stroke and Alzheimer's disease… Expand
428 Citations
Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond
  • S. Lipton
  • Chemistry, Medicine
  • Nature Reviews Drug Discovery
  • 2006
  • 723
Amide-containing NR2B/NMDA receptor antagonists
  • 8
Glutamate-based therapeutic approaches: NR2B receptor antagonists.
  • K. Gogas
  • Medicine
  • Current opinion in pharmacology
  • 2006
  • 160
Mechanism-based targeting of NMDA receptor functions
  • G. Popescu
  • Biology, Medicine
  • Cellular and Molecular Life Sciences CMLS
  • 2005
  • 22
Pathologically activated therapeutics for neuroprotection
  • S. Lipton
  • Medicine
  • Nature Reviews Neuroscience
  • 2007
  • 158
Clinically Tolerated Strategies for NMDA Receptor Antagonism
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
NMDA receptor antagonists as analgesics: focus on the NR2B subtype.
  • 189
Glycine-site antagonists and stroke.
  • 14
Glutamatergic mechanisms in schizophrenia.
  • 568
NMDA receptors as targets for drug action in neuropathic pain.
  • C. Parsons
  • Medicine
  • European journal of pharmacology
  • 2001
  • 209
D-serine added to antipsychotics for the treatment of schizophrenia
  • 604
Schizophrenia and glutamatergic transmission.
  • C. Tamminga
  • Medicine
  • Critical reviews in neurobiology
  • 1998
  • 386
...
1
2
3
4
5
...